These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 24319118)

  • 1. Boosting the power of schizophrenia genetics by leveraging new statistical tools.
    Andreassen OA; Thompson WK; Dale AM
    Schizophr Bull; 2014 Jan; 40(1):13-7. PubMed ID: 24319118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors.
    Andreassen OA; Djurovic S; Thompson WK; Schork AJ; Kendler KS; O'Donovan MC; Rujescu D; Werge T; van de Bunt M; Morris AP; McCarthy MI; ; ; ; Roddey JC; McEvoy LK; Desikan RS; Dale AM
    Am J Hum Genet; 2013 Feb; 92(2):197-209. PubMed ID: 23375658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research.
    Iyegbe C; Campbell D; Butler A; Ajnakina O; Sham P
    Soc Psychiatry Psychiatr Epidemiol; 2014 Feb; 49(2):169-82. PubMed ID: 24435092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All SNPs are not created equal: genome-wide association studies reveal a consistent pattern of enrichment among functionally annotated SNPs.
    Schork AJ; Thompson WK; Pham P; Torkamani A; Roddey JC; Sullivan PF; Kelsoe JR; O'Donovan MC; Furberg H; ; ; ; Schork NJ; Andreassen OA; Dale AM
    PLoS Genet; 2013 Apr; 9(4):e1003449. PubMed ID: 23637621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bivariate causal mixture model quantifies polygenic overlap between complex traits beyond genetic correlation.
    Frei O; Holland D; Smeland OB; Shadrin AA; Fan CC; Maeland S; O'Connell KS; Wang Y; Djurovic S; Thompson WK; Andreassen OA; Dale AM
    Nat Commun; 2019 Jun; 10(1):2417. PubMed ID: 31160569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPG: A four-group probabilistic approach to leveraging pleiotropy in genome-wide association studies.
    Yang Y; Dai M; Huang J; Lin X; Yang C; Chen M; Liu J
    BMC Genomics; 2018 Jun; 19(1):503. PubMed ID: 29954342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How powerful are summary-based methods for identifying expression-trait associations under different genetic architectures?
    Veturi Y; Ritchie MD
    Pac Symp Biocomput; 2018; 23():228-239. PubMed ID: 29218884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How can genetics help understand the relationship between cognitive dysfunction and schizophrenia?
    Smeland OB; Andreassen OA
    Scand J Psychol; 2018 Feb; 59(1):26-31. PubMed ID: 29356008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide approaches to schizophrenia.
    Duan J; Sanders AR; Gejman PV
    Brain Res Bull; 2010 Sep; 83(3-4):93-102. PubMed ID: 20433910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bayesian framework that integrates multi-omics data and gene networks predicts risk genes from schizophrenia GWAS data.
    Wang Q; Chen R; Cheng F; Wei Q; Ji Y; Yang H; Zhong X; Tao R; Wen Z; Sutcliffe JS; Liu C; Cook EH; Cox NJ; Li B
    Nat Neurosci; 2019 May; 22(5):691-699. PubMed ID: 30988527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New statistical approaches exploit the polygenic architecture of schizophrenia--implications for the underlying neurobiology.
    Schork AJ; Wang Y; Thompson WK; Dale AM; Andreassen OA
    Curr Opin Neurobiol; 2016 Feb; 36():89-98. PubMed ID: 26555806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
    Rudan I
    Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Empirical Bayes Mixture Model for Effect Size Distributions in Genome-Wide Association Studies.
    Thompson WK; Wang Y; Schork AJ; Witoelar A; Zuber V; Xu S; Werge T; Holland D; ; Andreassen OA; Dale AM
    PLoS Genet; 2015 Dec; 11(12):e1005717. PubMed ID: 26714184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pleiotropy informed adaptive association test of multiple traits using genome-wide association study summary data.
    Masotti M; Guo B; Wu B
    Biometrics; 2019 Dec; 75(4):1076-1085. PubMed ID: 31021400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GPA: a statistical approach to prioritizing GWAS results by integrating pleiotropy and annotation.
    Chung D; Yang C; Li C; Gelernter J; Zhao H
    PLoS Genet; 2014 Nov; 10(11):e1004787. PubMed ID: 25393678
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores in imaging genetics: Usefulness and applications.
    Dima D; Breen G
    J Psychopharmacol; 2015 Aug; 29(8):867-71. PubMed ID: 25944849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prioritization of schizophrenia risk genes from GWAS results by integrating multi-omics data.
    He D; Fan C; Qi M; Yang Y; Cooper DN; Zhao H
    Transl Psychiatry; 2021 Mar; 11(1):175. PubMed ID: 33731678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic architecture of schizophrenia: a review of major advancements.
    Legge SE; Santoro ML; Periyasamy S; Okewole A; Arsalan A; Kowalec K
    Psychol Med; 2021 Oct; 51(13):2168-2177. PubMed ID: 33550997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Genetics in Bipolar Disorder.
    Fabbri C
    Curr Top Behav Neurosci; 2021; 48():41-60. PubMed ID: 32767004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetics of psychiatric disorders in the GWAS era: an update on schizophrenia.
    Schwab SG; Wildenauer DB
    Eur Arch Psychiatry Clin Neurosci; 2013 Nov; 263 Suppl 2():S147-54. PubMed ID: 24071914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.